- Home
- Publications
- Publication Search
- Publication Details
Title
The role of STAT3 in tumor-mediated immune suppression
Authors
Keywords
STAT3, Glioblastoma, Immune suppression
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 123, Issue 3, Pages 385-394
Publisher
Springer Nature
Online
2015-02-21
DOI
10.1007/s11060-015-1731-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Modulating Antiangiogenic Resistance by Inhibiting the Signal Transducer and Activator of Transcription 3 Pathway in Glioblastoma
- (2015) John de Groot et al. Oncotarget
- Phosphorylated STAT3 and PD-1 regulate IL-17 production and IL-23 receptor expression inMycobacterium tuberculosisinfection
- (2014) Anuradha Bandaru et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells
- (2014) Andreas Herrmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Itk-mediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells
- (2014) Julio Gomez-Rodriguez et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Inhibition of STAT3 Promotes the Efficacy of Adoptive Transfer Therapy Using Type-1 CTLs by Modulation of the Immunological Microenvironment in a Murine Intracranial Glioma
- (2014) M. Fujita et al. JOURNAL OF IMMUNOLOGY
- STAT3 Tyr705 phosphorylation affects clinical outcome in patients with newly diagnosed supratentorial glioblastoma
- (2014) Guo-Shi Lin et al. MEDICAL ONCOLOGY
- Th17 Cells in Cancer: The Ultimate Identity Crisis
- (2014) Stefanie R. Bailey et al. Frontiers in Immunology
- STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications
- (2014) Jennifer Kim et al. Cancers
- Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans
- (2013) G. T. Gorgun et al. BLOOD
- miR-124 Inhibits STAT3 Signaling to Enhance T Cell–Mediated Immune Clearance of Glioma
- (2013) Jun Wei et al. CANCER RESEARCH
- STAT3 interacts with Skp2/p27/p21 pathway to regulate the motility and invasion of gastric cancer cells
- (2013) Zheng Wei et al. CELLULAR SIGNALLING
- The prognostic value of Foxp3+ tumor-infiltrating lymphocytes in patients with glioblastoma
- (2013) Qi Yue et al. JOURNAL OF NEURO-ONCOLOGY
- Tumor-associated macrophages in thoracic malignancies
- (2013) L.A. Lievense et al. LUNG CANCER
- Immune Heterogeneity of Glioblastoma Subtypes: Extrapolation from the Cancer Genome Atlas
- (2013) T. Doucette et al. Cancer Immunology Research
- The Activation of MAPK in Melanoma Cells Resistant to BRAF Inhibition Promotes PD-L1 Expression That Is Reversible by MEK and PI3K Inhibition
- (2012) X. Jiang et al. CLINICAL CANCER RESEARCH
- Stat3 and Gfi-1 Transcription Factors Control Th17 Cell Immunosuppressive Activity via the Regulation of Ectonucleotidase Expression
- (2012) Fanny Chalmin et al. IMMUNITY
- The role of STAT3 activation in modulating the immune microenvironment of GBM
- (2012) Alfred P. See et al. JOURNAL OF NEURO-ONCOLOGY
- Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma
- (2012) Tiffany A. Doucette et al. NEURO-ONCOLOGY
- The tumor microenvironment expression of p-STAT3 influences the efficacy of cyclophosphamide with WP1066 in murine melanoma models
- (2011) Mustafa Aziz Hatiboglu et al. INTERNATIONAL JOURNAL OF CANCER
- Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma
- (2011) B. Raychaudhuri et al. NEURO-ONCOLOGY
- Inhibition of p-STAT3 Enhances IFN- Efficacy against Metastatic Melanoma in a Murine Model
- (2010) L. Y. Kong et al. CLINICAL CANCER RESEARCH
- Intratumoral Mediated Immunosuppression is Prognostic in Genetically Engineered Murine Models of Glioma and Correlates to Immunotherapeutic Responses
- (2010) L.-Y. Kong et al. CLINICAL CANCER RESEARCH
- Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer
- (2010) Zhengbin Shen et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Down-Regulation of Stat3 Decreases Invasion Activity and Induces Apoptosis of Human Glioma Cells
- (2010) Fuxue Chen et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Activation of JAK/STAT signal pathway predicts poor prognosis of patients with gliomas
- (2010) Yanyang Tu et al. MEDICAL ONCOLOGY
- Glioblastoma Cancer-Initiating Cells Inhibit T-Cell Proliferation and Effector Responses by the Signal Transducers and Activators of Transcription 3 Pathway
- (2010) J. Wei et al. MOLECULAR CANCER THERAPEUTICS
- Glioma cancer stem cells induce immunosuppressive macrophages/microglia
- (2010) Adam Wu et al. NEURO-ONCOLOGY
- LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model
- (2009) B Fuh et al. BRITISH JOURNAL OF CANCER
- Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice
- (2009) Leying Zhang et al. GLIA
- The role of microglia in central nervous system immunity and glioma immunology
- (2009) Isaac Yang et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Mechanism Regulating Reactive Oxygen Species in Tumor-Induced Myeloid-Derived Suppressor Cells
- (2009) C. A. Corzo et al. JOURNAL OF IMMUNOLOGY
- Mechanisms of Local Immunoresistance in Glioma
- (2009) Emilia Albesiano et al. NEUROSURGERY CLINICS OF NORTH AMERICA
- STAT3 Is Required for Proliferation and Maintenance of Multipotency in Glioblastoma Stem Cells
- (2009) Maureen M. Sherry et al. STEM CELLS
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy
- (2008) C. Marcela Diaz-Montero et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A Novel Inhibitor of Signal Transducers And Activators Of Transcription 3 Activation Is Efficacious Against Established Central Nervous System Melanoma and Inhibits Regulatory T Cells
- (2008) L.-Y. Kong et al. CLINICAL CANCER RESEARCH
- The Incidence, Correlation with Tumor-Infiltrating Inflammation, and Prognosis of Phosphorylated STAT3 Expression in Human Gliomas
- (2008) M. Abou-Ghazal et al. CLINICAL CANCER RESEARCH
- Incidence and Prognostic Impact of FoxP3+ Regulatory T Cells in Human Gliomas
- (2008) A. B. Heimberger et al. CLINICAL CANCER RESEARCH
- Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives
- (2008) Paulo C. Rodríguez et al. IMMUNOLOGICAL REVIEWS
- Synergistic antitumor effects of CpG oligodeoxynucleotide and STAT3 inhibitory agent JSI-124 in a mouse melanoma tumor model
- (2008) Ommoleila Molavi et al. IMMUNOLOGY AND CELL BIOLOGY
- Immunomodulatory and anticancer effects of intra-tumoral co-delivery of synthetic lipid A adjuvant and STAT3 inhibitor, JSI-124
- (2008) Ommoleila Molavi et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Blockage of the STAT3 signaling pathway with a decoy oligonucleotide suppresses growth of human malignant glioma cells
- (2008) Jinhai Gu et al. JOURNAL OF NEURO-ONCOLOGY
- Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas
- (2008) Y Komohara et al. JOURNAL OF PATHOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started